SBI Pharma (India) Financial Indicators Patterns

We advise you to exercise SBI Pharma fundamental analysis to find out if markets are today mispricing the fund. In other words you can harness it to find out if SBI Pharma Reg is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We found seven available drivers for SBI Pharma Reg Gr which can be compared to its competition. Please use SBI Pharma Minimum Initial Investment to make a decision on weather SBI Pharma Reg is priced fairly.
3%3%

Chance of Financial Distress

SBI Pharma Reg Gr has less than 3 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

SBI Pharma Company Summary

SBI Pharma competes with Reliance Equity, and Invesco India. To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. SBI Pharma is traded on Bombay Stock Exchange in India.

SBI Pharma Equity Positions Weight vs Minimum Initial Investment

SBI Pharma Reg Gr is one of the top funds in equity positions weight among similar funds. It is one of the top funds in minimum initial investment among similar funds making about  54.00  of Minimum Initial Investment per Equity Positions Weight.

SBI Pharma Market Fundamentals

SBI Pharma Reg Gr is one of the top funds in net asset among similar funds. Total Asset Under Management (AUM) of Sector - Healthcare category is currently estimated at about 21.71 Billion. SBI Pharma claims roughly 328.95 Million in net asset contributing just under 2% to funds listed under Sector - Healthcare category.
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
See also Investing Opportunities. Please also try Equity Search module to search for activelly-traded equities including funds and etfs from over 30 global markets.
Search macroaxis.com